In a combotherapy using anti-PD-L1 and anti-TGFß on a mammary carcinoma murine model, she showed an expansion of CD8 T memory progenitors and reduction of CD8 precursor exhausted (Tpex) T-cells (34). The gene discussed is CD8A; the disease is breast carcinoma.